Home » Health » MoU Signed: Diabetes & Brain Health Research Collaboration

MoU Signed: Diabetes & Brain Health Research Collaboration

by Dr. Jennifer Chen

“`html

Collaboration Launched to Study Diabetes-Brain Health Link

Published: October 26, 2025, 5:30 am IST

Last ⁢Updated: October 27, 2025, 00:39:37 IST

Key Collaboration Details

The Madras‌ Diabetes⁤ Research foundation (MDRF) in Chennai, ‌the ​Center for ‌Brain Research (CBR) at ‌the Indian Institute of‍ Science (IISc) in ⁢Bengaluru, and the UK ‍Dementia⁤ Research⁣ Institute (UK DRI) have formalized a research collaboration to investigate⁣ the ​complex relationship between ⁢diabetes and brain health.A Memorandum of Understanding​ (MoU)⁢ was⁤ signed⁤ on Saturday, October 25, 2025, to initiate this joint effort.

The Interplay of ​Metabolic​ and Brain Health

The collaboration stems from a growing ⁤understanding that metabolic​ diseases,such as diabetes,considerably impact brain health,and conversely,brain health influences metabolic function.This bidirectional⁤ relationship underscores the need for an integrated⁣ approach to prevention and treatment. ‍ ‌As stated by researchers involved,⁢ addressing both aspects⁤ simultaneously⁤ is crucial for optimal health outcomes.

According ⁣to⁢ the press release, ⁤the⁣ initiative aims to leverage the expertise of each institution to unravel the underlying mechanisms driving this connection. This includes investigating how diabetes contributes to⁣ cognitive decline⁤ and neurodegenerative diseases,​ and how brain health impacts ⁢metabolic control.

Focus on Biomarkers and Early Detection

Henrik Zetterberg, Head of ‍the ⁤Department of Psychiatry and Neurochemistry at ⁢the University of Gothenburg and Group ⁤Leader at the ⁤UK DRI at UCL Queen Square Institute of Neurology, highlighted the importance of⁢ biomarkers in detecting early changes in the brain.He​ identified Alzheimer’s disease ⁣and cerebrovascular disease as the most common causes⁤ of‌ dementia. the UK DRI is actively working to develop a globally accessible and affordable biomarker panel for a ⁤wide range of neurodegenerative diseases.

Biomarkers offer the potential for earlier diagnosis and intervention, possibly slowing the progression of these debilitating conditions.Alzheimer’s Research UK ⁣ provides‌ detailed information‌ on different types of dementia and ongoing⁣ research efforts.

The Healthy ⁢Ageing Clinic and Cognitive Decline

S. Uthra, Senior ⁤Scientist at MDRF, described the assessment ⁤process at the Healthy ​Ageing‍ Clinic. Patients aged 60 and above undergo a simple questionnaire evaluating factors‍ including⁢ memory ⁢function. Data from the clinic demonstrates a clear correlation between age and the ⁣percentage of cognitive decline.

Uthra⁣ emphasized the critical need to integrate cognitive health ‍into comprehensive diabetes care.​ ⁤This holistic approach⁢ recognizes that managing diabetes effectively requires attention⁤ to both physical and ⁣mental well-being. The MDRF’s work underscores the importance of proactive⁤ cognitive screening for older adults,​ particularly those with diabetes.

Cognitive Decline and Age: MDRF data

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Age Group Percentage‌ with ‌Cognitive Decline (Example Data)